Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.

Albers-Schönberg disease, or autosomal dominant osteopetrosis, type II (ADO II), is the most common form of osteopetrosis, a group of conditions characterized by an increased skeletal mass due to impaired bone and cartilage resorption. Following the assignment of the gene causing ADO II to chromosome 16p13.3, we now report seven different mutations in the gene encoding the ClCN7 chloride channel in all 12 ADO II families analysed. Additionally, a patient with the severe, autosomal recessive, infantile form of osteopetrosis (ARO) was identified as being homozygous for a ClCN7 mutation. From genotype-phenotype correlations, it seems that ADO II reflects a dominant negative effect, whereas loss-of-function mutations in ClCN7 do not cause abnormalities in heterozygous individuals. Because some ARO patients have mutations in both copies of the ClCN7 gene, ADO II is allelic with a subset of ARO cases.

[1]  W. Hul,et al.  Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3. , 2001, American journal of human genetics.

[2]  W. Hul,et al.  Exclusion of the chromosomal 1p21 region in a large pedigree with a phenotypic variant of type II autosomal dominant osteopetrosis , 2001 .

[3]  J. Peden,et al.  Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. , 2001, Human molecular genetics.

[4]  A. Schulz,et al.  Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man , 2001, Cell.

[5]  W. Hul,et al.  Further Evidence for Genetic Heterogeneity Within Type II Autosomal Dominant Osteopetrosis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  A. Schulz,et al.  Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. , 2000, Human molecular genetics.

[7]  L. Notarangelo,et al.  Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis , 2000, Nature Genetics.

[8]  T. Friedrich,et al.  The CLC chloride channel family , 1999, Pflügers Archiv.

[9]  T. Foroud,et al.  Locus heterogeneity of autosomal dominant osteopetrosis (ADO). , 1999, The Journal of clinical endocrinology and metabolism.

[10]  B. Bénichou,et al.  Osteopetrosis as a model for studying bone resorption. , 1998, Revue du rhumatisme.

[11]  M. Hechenberger,et al.  Golgi Localization and Functionally Important Domains in the NH2 and COOH Terminus of the Yeast CLC Putative Chloride Channel Gef1p* , 1998, The Journal of Biological Chemistry.

[12]  A. George,et al.  Pore-forming segments in voltage-gated chloride channels , 1997, Nature.

[13]  W. Hul,et al.  Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21. , 1997, American journal of human genetics.

[14]  T. Jentsch,et al.  Transmembrane topology of a CLC chloride channel. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T A Einhorn,et al.  Fractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  Thomas J. Jentsch,et al.  Two physically distinct pores in the dimeric CIC-0 chloride channel , 1996, Nature.

[17]  A. Fischer,et al.  Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. , 1994, Pediatrics.

[18]  M. Crackower,et al.  Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita) , 1993, Nature Genetics.

[19]  J. W. Pendleton,et al.  Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis Type II — a family study , 1992, Clinical genetics.

[20]  J. Goldblatt,et al.  Autosomal dominant osteopetrosis type II with “malignant” presentation: further support for heterogeneity? , 1990, Clinical genetics.

[21]  J. Bollerslev.  Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects. , 1989, Endocrine reviews.

[22]  J. Bollerslev,et al.  Heterogeneity of autosomal dominant osteopetrosis. , 1987, Radiology.

[23]  J. Bollerslev,et al.  Osteopetrosis. A genetic and epidemiological study. , 2008, Clinical genetics.

[24]  A. Aylsworth,et al.  A mild autosomal recessive form of osteopetrosis. , 1984, American journal of medical genetics.

[25]  D. Hewett‐Emmett,et al.  Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Horton,et al.  Osteopetrosis: further heterogeneity. , 1980, The Journal of pediatrics.

[27]  J. Laredo,et al.  Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. , 2000, Bone.

[28]  A. Bateman.  The structure of a domain common to archaebacteria and the homocystinuria disease protein. , 1997, Trends in biochemical sciences.

[29]  J. Bollerslev,et al.  Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. , 1988, Bone.

[30]  H. Gruber,et al.  Skeletal remodelling and bone related hormones in two adults with increased bone mass. , 1982, Metabolism: clinical and experimental.